» Articles » PMID: 32253259

LPIAT1/MBOAT7 Depletion Increases Triglyceride Synthesis Fueled by High Phosphatidylinositol Turnover

Abstract

Objective: Non-alcoholic fatty liver disease (NAFLD) is a common prelude to cirrhosis and hepatocellular carcinoma. The genetic variant in the lysophosphatidylinositol acyltransferase 1 (, which incorporates arachidonic acid into phosphatidylinositol (PI), is associated with the entire spectrum of NAFLD. In this study, we investigated the mechanism underlying this association in mice and cultured human hepatocytes.

Design: We generated the hepatocyte-specific knockout mice to investigate the function of Lpiat1 in vivo. We also depleted in cultured human hepatic cells using CRISPR-Cas9 systems or siRNA. The effect of LPIAT1-depletion on liver fibrosis was examined in mice fed high fat diet and in liver spheroids. Lipid species were measured using liquid chromatography-electrospray ionisation mass spectrometry. Lipid metabolism was analysed using radiolabeled glycerol or fatty acids.

Results: The hepatocyte-specific knockout mice developed hepatic steatosis spontaneously, and hepatic fibrosis on high fat diet feeding. Depletion of in cultured hepatic cells and in spheroids caused triglyceride accumulation and collagen deposition. The increase in hepatocyte fat content was due to a higher triglyceride synthesis fueled by a non-canonical pathway. Indeed, reduction in the PI acyl chain remodelling caused a high PI turnover, by stimulating at the same time PI synthesis and breakdown. The degradation of PI was mediated by a phospholipase C, which produces diacylglycerol, a precursor of triglyceride.

Conclusion: We found a novel pathway fueling triglyceride synthesis in hepatocytes, by a direct metabolic flow of PI into triglycerides. Our findings provide an insight into the pathogenesis and therapeutics of NAFLD.

Citing Articles

Silybin A from reprograms lipid metabolism to induce a cell fate-dependent class switch from triglycerides to phospholipids.

Koeberle S, Thurmer M, Su F, Werner M, Grander J, Hofer L Theranostics. 2025; 15(5):2006-2034.

PMID: 39897559 PMC: 11780512. DOI: 10.7150/thno.99562.


Diacylglycerol Kinases and Its Role in Lipid Metabolism and Related Diseases.

Liu Y, Yang Z, Zhou X, Li Z, Hideki N Int J Mol Sci. 2024; 25(23).

PMID: 39684917 PMC: 11643042. DOI: 10.3390/ijms252313207.


Metabolomics at the cutting edge of risk prediction of MASLD.

Tan E, Muthiah M, Sanyal A Cell Rep Med. 2024; 5(12):101853.

PMID: 39657668 PMC: 11722125. DOI: 10.1016/j.xcrm.2024.101853.


Dietary inositol supplementation improves meat quality by modulating amino acid metabolism and gut microbiota composition of finishing pigs.

Yan E, Sun H, He L, Wan B, Shen M, Miao Q Anim Nutr. 2024; 19:180-191.

PMID: 39635421 PMC: 11615912. DOI: 10.1016/j.aninu.2024.05.012.


Flow-mediated modulation of the endothelial cell lipidome.

Hong S, Kennelly J, Williams K, Bensinger S, Mack J Front Physiol. 2024; 15:1431847.

PMID: 39119214 PMC: 11307263. DOI: 10.3389/fphys.2024.1431847.


References
1.
Prill S, Caddeo A, Baselli G, Jamialahmadi O, Dongiovanni P, Rametta R . The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids. Sci Rep. 2019; 9(1):11585. PMC: 6690969. DOI: 10.1038/s41598-019-47737-w. View

2.
Helsley R, Varadharajan V, Brown A, Gromovsky A, Schugar R, Ramachandiran I . Obesity-linked suppression of membrane-bound -acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease. Elife. 2019; 8. PMC: 6850774. DOI: 10.7554/eLife.49882. View

3.
Johansen A, Rosti R, Musaev D, Sticca E, Harripaul R, Zaki M . Mutations in MBOAT7, Encoding Lysophosphatidylinositol Acyltransferase I, Lead to Intellectual Disability Accompanied by Epilepsy and Autistic Features. Am J Hum Genet. 2016; 99(4):912-916. PMC: 5065650. DOI: 10.1016/j.ajhg.2016.07.019. View

4.
Dongiovanni P, Stender S, Pietrelli A, Mancina R, Cespiati A, Petta S . Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver. J Intern Med. 2017; 283(4):356-370. PMC: 5900872. DOI: 10.1111/joim.12719. View

5.
Hansson P, Asztely A, Clapham J, Schreyer S . Glucose and fatty acid metabolism in McA-RH7777 hepatoma cells vs. rat primary hepatocytes: responsiveness to nutrient availability. Biochim Biophys Acta. 2004; 1684(1-3):54-62. DOI: 10.1016/j.bbalip.2004.06.005. View